USPTO serial 79273309
X10D
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 8, 2021
- Examiner
- GALANTE, JOSHUA MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with X10D?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Hynak
Michael J. Hynak Hynak & Associates, PC812 South Courthouse Rd.Arlington, VA 22204UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and solutions for transport, storage, managing, assessment and treatment of tissues and organs; pharmaceutical preparations and solutions for use in organ transplantation; pharmaceutical preparations and solutions for use in heart transplantation; pharmaceutical preparations and solutions for use in lung transplantation | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research and design in the field of solutions and devices for organ, tissue and cell preservation, perfusion and evaluation in connection to transplantation, and medical device for cardiothoracic surgery; industrial analysis and research services in the field of solutions and devices for organ, tissue and cell preservation, perfusion and evaluation in connection to transplantation, and medical device for cardiothoracic surgery; design and development of computer hardware and software; medical and pharmacological research services; scientific research for medical purposes in the field of solutions and devices for organ, tissue and cell preservation, perfusion and evaluation in connection to transplantation, and medical device for cardiothoracic surgery; Medical research in the nature of analysis of human tissues; design and development of medical diagnostic apparatus; design and development of medical technology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Xvivo Perfusion Aktiebolag
- Other trademarks owned by Xvivo Perfusion Aktiebolag
- Other trademarks owned by Xvivo Perfusion Aktiebolag
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named X10D
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 8, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 25, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 24, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 27, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 27, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 8, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 8, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 23, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 5, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 5, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 21, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 3, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 3, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 16, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 16, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 16, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 16, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 16, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 22, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 3, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 3, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 3, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 3, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 3, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 3, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 24, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 7, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 7, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 10, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 10, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 9, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 6, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |